TREATMENT OF BRONCHOPULMONARY DYSPLASIA - A REVIEW

Bronchopulmonary dysplasia (BPD), first described in 1966, remains an issue of both clinical and public health importance. BPD may be associ ated with chronic respiratory difficulties, prolonged and recurrent ho spitalization, an increased incidence of neurodevelopmental disabiliti es, growth restriction, and death. Controversies regarding the cause o f BPD are important to resolve in an attempt to develop strategies for prevention.